Adherium grows monitoring subscription revenue as Hailie usage rises

what happened

According to smallcaps.com.au, Adherium lifted its remote patient monitoring (RPM) subscription revenue by 12.5% in the September quarter, to $539,000. It was the fifth quarterly record in a row. Customer receipts reached $544,000, up 33% from the previous quarter.

During the three months the company shipped 1,033 more Hailie devices and activated 900. Cumulative totals now stand at 6,392 shipments and 4,732 activations. Subscription revenue was 381% higher than in the September 2025 quarter, as billable revenue is recognised when a patient activates a device rather than when it ships. More than 90% of Allergy Partners clinic locations already take part in the program.

Adherium is preparing to move toward value-based care contracts with insurers and health systems, where payment depends on patient outcomes. At the same time, it is assessing the changes to Medicare reimbursement for monitoring services proposed in July. A final rule was expected in November and may differ from the July proposal.

why it matters

For investors, the key question is whether Adherium can turn subscription growth and clinical data into payer partnerships, and how Medicare rules will affect its current reimbursement model. The company stresses that no such contracts have been won yet.

tags

instruments